¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø¡¤´ëÇÑÀ̽ÄÇÐȸ ¡®±è¼öȯÃß±â°æ ±â³ä¡¯ °øµ¿ÁÖÃÖ ½ÉÆ÷Áö¾ö : 2022-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø¡¤´ëÇÑÀ̽ÄÇÐȸ ¡®±è¼öȯÃß±â°æ ±â³ä¡¯ °øµ¿ÁÖÃÖ ½ÉÆ÷Áö¾ö : 2022-09-03
±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç  
±³À°ÁÖÁ¦ : 2022³â °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø¡¤´ëÇÑÀ̽ÄÇÐȸ ¡®±è¼öȯÃß±â°æ ±â³ä¡¯ °øµ¿ÁÖÃÖ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÀ̽ÄÇÐȸ
´ã´çÀÚ : ÀºÆò¼º¸ðº´¿ø
¿¬¶ôó : 02-3144-2227  
À̸ÞÀÏ : info@chiron.co.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 09:10~09:25 Clinical outcomes of KT living donor with chronic disease  ¹ÝÅÂÇö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 09:25~09:40 Clinical significanceof ABO-incompatible kidney transplantation in elderly recipients  Çã±ÔÇÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 09:40~09:55 Unexpected post-KT cardiovascular complication and management  ¹Ú¼øö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 09:55~10:10 KT deceased donor with acute kidney injury  ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 10:10~10:30 An overview of the current management of short-bowel syndrome  Alan N Langnas(UNMC, Omaha, NE, USA) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 10:30~10:50 Post-transplant management and Graft surveillance in small bowel transplantation  Jang Moon(Mount Sinai, NY, USA) 
Åä·Ð 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 10:50~11:00 Discussion  () 
È޽Ġ09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 11:00~11:10 Break  () 
±âŸ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 11:10~11:40 ±è¼öȯÃß±â°æ°ú ÇÔ²²ÇÑ ¶óÆÄ¿¤ Ŭ¸®´Ð  ¾È±Ô¸®(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±âŸ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 11:40~12:10 °¡Å縯´ëÇб³ ½ÅÀåÀ̽İú ÀºÆò¼º¸ðº´¿ø Àå±âÀ̽ĺ´¿øÀÇ ³ª¾Æ°¥ ±æ  ¾çö¿ì(°¡Å縯ÀÇ´ë) 
½Ä»ç 09-03  12:10~13:10 Lunch  () 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 13:10~13:30 Immune tolerence in liver transplantation  ÃÖÁ¾¿µ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 13:30~13:50 Expanded criteria for hepatocellular carcinoma in liver transplantation  ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 13:50~14:10 ABO-incompatible liver transplantation  ¼Û±â¿ø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 14:10~14:30 Donor ion and safety in living donor Liver Transplantation  ¹ÚÁ¤Çö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 14:30~14:45 Complications after heart transplantation - an update  ¼­¼®¹Î(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 14:45~15:00 Anesthetic consideration post-cardiac transplant recipient  ÀüÁØÇ¥(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 15:00~15:15 Current Trends of lung transplantation - optimal strategies for establishmentof program  Ãֽÿµ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 15:15~15:30 Pulmonary rehabilitation after lung transplantation  ¹ÚÁöÇý(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 15:30~15:45 Experience of starting a lung transplant program  ÇÔ¼®Áø(¾ÆÁÖÀÇ´ë) 
È޽Ġ09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 15:45~16:00 Break  () 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 16:00~16:30 ±è¼öȯÃß±â°æ°ú °¢¸·À̽Ġ ±è¸¸¼ö(°­³²¼º¸ð¿ø¾È°ú) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 16:30~16:45 Impact of Performed and de novo DSA in KT, and Update of Monitoring Strategy  ÀÓÁöÇâ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 16:45~17:00 Treatment recommendations for acute and chronic ABMR  Á¤º´ÇÏ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 17:00~17:15 Robot-assisted kidney transplantation in immunological high-risk patients  ½Å¼º(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°­´ç 17:15~17:35 Report of past three year transplants at 'Cadinal Stephen Kim Memorial' Transplant hospital  È²Á¤±â(°¡Å縯ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 Ãß°è½ÉÆ÷Áö¾ö : 2022-09-03
´ÙÀ½±Û 2022 ´ëÇÑ°¨¿°ÇÐȸ Àü°øÀÇ¿Í Àü¹®ÀǸ¦ À§ÇÑ Ãß°è °¨¿°ÇÐ ¿¬¼ö°­Á : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
300 ¼­¿ï ´ëÇѳëÀκ´ÇÐȸ Á¦ 38Â÷ ÀÎÁ¤ÀÇ ¿¬¼ö°­Á : 2018-08-19 0 772 2018-08-08
299 ¼­¿ï 2018 ÀÇ·áÄ¿¹Â´ÏÄÉÀÌ¼Ç ±³À°Àü·« ¿öÅ©¼ó : 2018-08-18 0 541 2018-08-08
298 °æ±â ´ëÇÑôÃßÁ¾¾ç¿¬±¸È¸ Á¦18Â÷ Çмú´ëȸ : 2018-08-18 0 1,034 2018-08-08
297 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ iTHA (Innovation & Technology in Hip Athroplasty) : 2018-08-18 0 1,208 2018-08-08
296 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-18 0 612 2018-08-08
295 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 Kyung Hee Neurosurgery Symposium (ÀÓ¿µÁø ±³¼ö´Ô Á¤³â±â³ä ½ÉÆ÷Áö¿ò) : 2018-08-18 0 1,541 2018-08-08
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 636 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,094 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 926 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 563 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,160 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 880 2018-07-28
288 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ¿¬±Ø¼º ÀΰÝÀå¾Ö, ÀÇÁ¸¼º ÀΰÝÀå¾Ö : 2018-09-29 0 1,254 2018-07-28
287 ¼­¿ï 2018 ´ëÇÑâ»óÇÐȸ ±³À°½ÉÆ÷Áö¾ö : 2018-09-29 0 628 2018-07-28
286 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(CSC treatment update) : 2018-09-28 0 1,115 2018-07-28
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷